Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Amgen h ve medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and we are also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Reaching Seriously Ill Patients Worldwide We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on four therapeutic areas, general medicine, rare disease, inflammation, and oncology, delivering innovative medicines to help people live longer, fuller, happier lives. Investing in Science and Innovation We pursue new ways to do science using tools like AI, generative biology and human data to discover what is not yet known and develop new precision medicines to fight the world’s toughest diseases. Making Medicines Safely and Reliably Many of Amgen's medicines are made through a highly complex process involving living cells. Our commitment is to deliver for "every patient, every time", and we have a long-running reputation for the reliability of our supply chain. Operating Responsibly Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines. We also help build a better world by focusing on environmental, social and governance issues that matter most to our business and our stakeholders. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients around the world. Amgen performed well in 2023, serving millions of patients around the world with our innovative, life-changing medicines; advancing many promising new first-in-class molecules in our pipeline; completing a significant acquisition that establishes us as a leader in treating rare diseases; and delivering strong financial performance. Amgen has been the recipient of numerous awards and accolades over the years, ranging from recognition of our pioneering science and innovation, philanthropy and corporate social responsibility to our commitment to being a great place to work. ...view more